Browse by Section 100 Item List

Highly Specialised Drugs Program (Community Access)

The Highly Specialised Drugs (HSD) Community Access arrangements align existing Section 100 HSD Program arrangements with current clinical practice and models of care, through improvements to the way some medicines are prescribed, dispensed and accessed under the s100 HSD Program. Medicines under HSD Community Access arrangements include:

  • clozapine for the treatment of schizophrenia (maintenance therapy only)
  • HIV antiretroviral medicines
  • hepatitis B medicines
  • opioid dependence medicines (see Opioid Dependence Treatment (ODT) Program)
  • lanreotide
  • octreotide.

These arrangements remove the requirement for patients and prescribers to be affiliated with a hospital setting.  Patients also have greater choice about where they access their medicines, through either a community pharmacy, or a private or public hospital pharmacy. Community pharmacists can dispense these medicines regardless of where the medicine is prescribed.

The remuneration rates for HSDs dispensed through community pharmacies are aligned to those paid to private hospitals which comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:

  • 10% for drugs with an ex-manufacturer price of less than $40
  • $4 for drugs with an ex-manufacturer price of between $40 and $100
  • 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
  • $40 for drugs with an ex-manufacturer price of greater than $1000.

Patient eligibility criteria are unchanged. Patients will continue to pay a patient co-payment which will contribute to the PBS Safety Net Record.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs 		Max qty
units 		No. of
repeats
MPNP 10320E LAMIVUDINElamivudine 10 mg/mL oral liquid, 240 mL 8 8 5
MPNP 10315X LAMIVUDINElamivudine 100 mg tablet, 28 2 56 5
MPNP 10348P LAMIVUDINElamivudine 150 mg tablet, 60 2 120 5
MPNP 10311Q LAMIVUDINElamivudine 300 mg tablet, 30 2 60 5
MPNP 10284G LAMIVUDINE + ZIDOVUDINElamivudine 150 mg + zidovudine 300 mg tablet, 60 2 120 5
MP 11289E LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 11736Q LANREOTIDElanreotide 120 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 11315M LANREOTIDElanreotide 60 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MP 11316N LANREOTIDElanreotide 90 mg/0.5 mL injection, 0.5 mL syringe 2 2 5
MPNP 10327M LOPINAVIR + RITONAVIRlopinavir 400 mg/5 mL + ritonavir 100 mg/5 mL oral liquid, 60 mL 10 10 5
MPNP 10272P LOPINAVIR + RITONAVIRlopinavir 200 mg + ritonavir 50 mg tablet, 120 2 240 5